MYmAb Biologics Recognized as a BioNexus Status Company March 2025 – We are thrilled to announce that MYmAb Biologics has been awarded BioNexus Status by the Bioeconomy Corporation. This prestigious recognition marks a significant milestone in our mission to drive…
How Tissue Microarrays (TMA) Contribute to Translational Research: Bridging the Gap Between Lab and Clinic What is Translational Research? In today’s rapidly advancing medical field, translational research is the engine that turns fundamental scientific findings into useful medical therapies. The…
Digital Pathology – An Advanced Way to Preserve Your Research Outcome In today’s rapidly evolving world of medical and scientific research, digital pathology has emerged as a cutting-edge solution that revolutionises the way pathologists and researchers approach diagnostics and data…